Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A disease involving the renal system.
Biomarker and diagnostic research for urinary system disorder has been reported in the published literature.
46 clinical trials registered, 21 recruiting. Interventions under study include drug therapy, other interventions, and medical devices. Pipeline includes 2 PHASE3, 3 PHASE2, 4 PHASE1. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT06676527](https://clinicaltrials.gov/study/NCT06676527) |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 11:56 AM UTC
Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma |
— |
Jinling Hospital, China |
RECRUITING |
[NCT06858319](https://clinicaltrials.gov/study/NCT06858319) | Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy. | PHASE3 | Novartis Pharmaceuticals | RECRUITING |
[NCT07435844](https://clinicaltrials.gov/study/NCT07435844) | Effect of Comprehensive Spa Care on Kidney and Urological Conditions: A Clinical Study in Adult Patients | NA | Institute of Spa and Balneology, public research institution | RECRUITING |
[NCT05949567](https://clinicaltrials.gov/study/NCT05949567) | Does Position Influence the Diagnosis of Detrusor Overactivity in a Neurological Population | NA | Assistance Publique - Hôpitaux de Paris | RECRUITING |
[NCT05153694](https://clinicaltrials.gov/study/NCT05153694) | Infectious Complications After Cystectomy: A Prospective Observational Study | — | Ludwig-Maximilians - University of Munich | RECRUITING |
264 publications have been identified in PubMed for urinary system disorder. Research spans Review / Meta-Analysis (52%), Basic Science / Preclinical (19%), and Epidemiology / Natural History (10%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 137 | 52% |
Laboratory research | 51 | 19% |
Disease patterns and progression | 27 | 10% |
Testing and diagnosis research | 12 | 5% |
New treatment approaches | 11 | 4% |
Clinical study results | 10 | 4% |
Patient case studies | 9 | 3% |
Other research | 7 | 3% |
Graafen L (2026). [PMID: 41831046](https://pubmed.ncbi.nlm.nih.gov/41831046/). *J Clin Immunol*. [Diagnostic / Biomarker]
David C (2026). [PMID: 41805977](https://pubmed.ncbi.nlm.nih.gov/41805977/). *J Exp Med*. [Case Report / Case Series]
Ansari S (2026). [PMID: 41931118](https://pubmed.ncbi.nlm.nih.gov/41931118/). *Antonie Van Leeuwenhoek*. [Review / Meta-Analysis]
Xiang H (2026). [PMID: 42143896](https://pubmed.ncbi.nlm.nih.gov/42143896/). *Biosens Bioelectron*. [Review / Meta-Analysis]
Zeng L (2026). [PMID: 42091254](https://pubmed.ncbi.nlm.nih.gov/42091254/). *Ren Fail*. [Review / Meta-Analysis]
Wang M (2026). [PMID: 41750255](https://pubmed.ncbi.nlm.nih.gov/41750255/). *Biomolecules*. [Review / Meta-Analysis]
Girish V (2026). [PMID: 28613606](https://pubmed.ncbi.nlm.nih.gov/28613606/). *Unknown Journal*. [Other]
Mora-Vázquez P (2026). [PMID: 41827341](https://pubmed.ncbi.nlm.nih.gov/41827341/). *J Clin Med*. [Epidemiology / Natural History]
Amado C (2026). [PMID: 40975490](https://pubmed.ncbi.nlm.nih.gov/40975490/). *Ann Allergy Asthma Immunol*. [Review / Meta-Analysis]
Neri L (2026). [PMID: 41208283](https://pubmed.ncbi.nlm.nih.gov/41208283/). *Curr Opin Nephrol Hypertens*. [Review / Meta-Analysis]